Colin O. Wu

Colin O. Wu

Auto-generated profile, based on publicly available information

Colin O. Wu

Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, MD

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2019 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
DLDaniel J Lim
Daniel J Lim
BABharath Ambale-Ventakesh
Bharath Ambale-Ventakesh
MOMohammad R Ostovaneh
Mohammad R Ostovaneh
TZTarek Zghaib
Tarek Zghaib
HAHiroshi Ashikaga
Hiroshi Ashikaga
JLJoao A. C. Lima
Joao A. C. Lima
Aims: Longitudinal change in left atrial (LA) structure and function could be helpful in predicting risk for incident atrial fibrillation (AF). We used cardiac magnetic resonance (CMR) imaging to explore the relationship between change in LA structure and function and incident AF in a multi-ethnic population free of clinical cardiovascular disease at baseline. Methods and results: In the Multi-Ethnic Study of Atherosclerosis (MESA), 2338 participants, free at baseline of clinically recognized AF and cardiovascular disease, had LA volume and function assessed with CMR imaging, at baseline (2000–02), and at Exam 4 (2005–07) or 5 (2010–12). Free of AF, 124 participants developed AF over 3.8 ± 0.9 years (2015) following the second imaging. In adjusted Cox regression models, an average annualized change in all LA parameters were significantly associated with an increased risk of AF. An annual decrease of 1-SD unit in total LA emptying fractions (LAEF) was most strongly associated with risk of AF after adjusting for clinical risk factors for AF, baseline LA parameters, and left ventricular mass-to-volume ratio (hazard ratio per SD = 1.91, 95% confidence interval = 1.53–2.38, P < 0.001). The addition of change in total LAEF to an AF risk score improved model discrimination and reclassification (net reclassification improvement = 0.107, P = 0.017; integrative discrimination index = 0.049, P < 0.001). Conclusion: In this multi-ethnic study population free of clinical cardiovascular disease at baseline, a greater increase in LA volumes and decrease in LA function were associated with incident AF. The addition of change in total LAEF to risk prediction models for AF improved model discrimination and reclassification of AF risk.

1 February 2023 in Radiology
Verified
Journal Article
Closed access
CMCharlène A. Mauger
Charlène A. Mauger
KGKathleen Gilbert
Kathleen Gilbert
ASAvan Suinesiaputra
Avan Suinesiaputra
DBDavid A. Bluemke
David A. Bluemke
CWColin O. Wu
Colin O. Wu
BVBharath Ambale Venkatesh
Bharath Ambale Venkatesh
Cardiac MRI–derived, left ventricular, event-specific remodeling signatures provided quantitative information on subclinical disease and were more predictive of 10-year cardiovascular events than s... Background Left ventricular (LV) subclinical remodeling is associated with adverse outcomes and indicates mechanisms of disease development. Standard metrics such as LV mass and volumes may not cap...

17 June 2024 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
DLDaniel J Lim
Daniel J Lim
VVVinithra Varadarajan
Vinithra Varadarajan
TQThiago Quinaglia
Thiago Quinaglia
TPTheo Pezel
Theo Pezel
CWColin Wu
Colin Wu
JLJoao A C Lima
Joao A C Lima
The role of change in left atrial (LA) parameters prior to the onset of heart failure (HF) remains unclear. We used cardiac magnetic resonance (CMR) imaging to investigate the relationship between longitudinal change in LA function and incident HF in a multi-ethnic population with subclinical cardiovascular disease (CVD). In this prospective multi-ethnic cohort study, 2470 participants (60 ± 9 years, 47% males), free at baseline of clinical CVD, had LA volume and function assessed via multimodality tissue tracking on CMR imaging at baseline (2000–02) and a second study 9.4 ± 0.6 years later. Free of HF, 73 participants developed incident HF [HF with preserved ejection fraction (HFpEF), n = 39; reduced ejection fraction (HFrEF), n = 34] 7.1 ± 2.1 years after the second study. An annual decrease of 1 SD unit in peak LA strain (ΔLASmax) was most strongly associated with the risk of HFpEF [subdistribution hazard ratios (HR) = 2.56, 95% confidence interval (CI) (1.34–4.90), P = 0.004] and improved model reclassification and discrimination in predicting HFpEF [C-statistic = 0.84, 95% CI (0.79–0.90); net reclassification index (NRI) = 0.34, P = 0.01; and integrated discrimination index (IDI) = 0.02, P = 0.02], whilst an annual decrease of 1 mL/m2 of pre-atrial indexed LA volumes (ΔLAVipreA) was most strongly associated with the risk of HFrEF [subdistribution HR = 1.88, 95% CI (1.44–2.45), P < 0.001] and improved model reclassification and discrimination in predicting HFrEF [C-statistic = 0.81, 95% CI (0.72–0.90); NRI = 0.31, P = 0.03; and IDI = 0.01, P = 0.50] after adjusting for event-specific risk factors and baseline LA measures. ΔLASmax and ΔLAVipreA were associated with and incrementally predictive of HFpEF and HFrEF, after adjusting for risk factors and baseline LA measures in this population of subclinical CVD. HF, heart failure; HFpEF, HF with preserved ejection fraction; LA, left atrial; Δ, change.

10 March 2024 in British Journal of Haematology
Verified
Journal Article
Open access
BDBrynn B. Duncan
Brynn B. Duncan
JLJennifer L. Lotter
Jennifer L. Lotter
JSJeanine Superata
Jeanine Superata
MBMa Evette Barranta
Ma Evette Barranta
TMTania Machado
Tania Machado
DYDavid J. Young
David J. Young
Summary: Diamond–Blackfan anaemia (DBA) is a rare, inherited bone marrow failure syndrome with a ribosomal defect causing slowed globin chain production with normal haem synthesis, causing an overabundance of reactive iron/haem and erythroid‐specific cellular toxicity. Eltrombopag, a non‐peptide thrombopoietin receptor agonist, is a potent intracellular iron chelator and induced a robust durable response in an RPS19‐mutated DBA patient on another trial. We hypothesized eltrombopag would improve RBC production in DBA patients. We conducted a single‐centre, single‐arm pilot study (NCT04269889) assessing safety and erythroid response of 6 months of daily, fixed‐dose eltrombopag for DBA patients. Fifteen transfusion‐dependent (every 3–5 weeks) patients (median age 18 [range 2–56]) were treated. One responder had sustained haemoglobin improvement and >50% reduction in RBC transfusion frequency. Of note, 7/15 (41%) patients required dose reductions or sustained discontinuation of eltrombopag due to asymptomatic thrombocytosis. Despite the low response rate, eltrombopag has now improved erythropoiesis in several patients with DBA with a favourable safety profile. Dosing restrictions due to thrombocytosis may cause insufficient iron chelation to decrease haem production and improve anaemia in most patients. Future work will focus on erythropoiesis dynamics in patients and use of haem synthesis inhibitors without an impact on other haematopoietic lineages.

7 February 2023 in Journal of the American Heart Association
Verified
Journal Article
Closed access
MDMaria Doughan
Maria Doughan
OCOmar Chehab
Omar Chehab
HVHenrique Doria de Vasconcellos
Henrique Doria de Vasconcellos
RZRalph Zeitoun
Ralph Zeitoun
VVVinithra Varadarajan
Vinithra Varadarajan
JLJoao A. C. Lima
Joao A. C. Lima
Background: Periodontitis is a chronic inflammatory disease common among adults. It has been suggested that periodontal disease (PD) may be a contributing risk factor for cardiovascular disease; however, pathways underlying such a relationship require further investigation. Methods and Results: A total of 665 men (mean age 68±9 years) and 611 women (mean age 67±9 years) enrolled in the MESA (Multiethnic Study of Atherosclerosis) underwent PD assessment using a 2‐item questionnaire at baseline (2000–2002) and had cardiovascular magnetic resonance 10 years later. PD was defined when participants reported either a history of periodontitis or gum disease or lost teeth caused by periodontitis or gum disease. Multivariable linear regression models were constructed to assess the associations of baseline self‐reported PD with cardiovascular magnetic resonance–obtained measures of interstitial myocardial fibrosis (IMF), including extracellular volume and native T1 time. Men with a self‐reported history of PD had greater extracellular volume percent (ß=0.6%±0.2, P =0.01). This association was independent of age, left ventricular mass, traditional cardiovascular risk factors, and history of myocardial infarction. In a subsequent model, substituting myocardial infarction for coronary artery calcium score, the association of PD with IMF remained significant (ß=0.6%±0.3, P =0.03). In women, a self‐reported history of PD was not linked to higher IMF. Importantly, a self‐reported history of PD was not found to be associated with myocardial scar independent of sex (odds ratio, 1.01 [95% CI, 0.62–1.65]; P =0.9). Conclusions: In a community‐based setting, men but not women with a self‐reported PD history at baseline were found to be associated with increased measures of IMF. These findings support a plausible link between PD, a proinflammatory condition, and subclinical IMF.

22 October 2024 in British Journal of Haematology
Verified
Journal Article
Open access
HLHaiou Li
Haiou Li
VSVandana Sachdev
Vandana Sachdev
XTXin Tian
Xin Tian
MNMy‐Le Nguyen
My‐Le Nguyen
MHMatthew Hsieh
Matthew Hsieh
STSwee Lay Thein
Swee Lay Thein
Summary: Allogeneic haematopoietic cell transplantation (HCT) with HLA‐matched sibling donor remains the most established curative therapeutic option for patients with sickle cell disease (SCD). However, it is not without risks, highlighting the need for a risk stratification system. Utilizing a machine learning (ML) approach that combines clinical and imaging variables, we identified red cell distribution width and renal organ damage as important risk factors for patients undergoing HCT. This ML‐based algorithm, similar to an approach previously reported for predicting mortality in patients with SCD, should be applicable to risk factor discovery in similar studies.